RHO and retinal degeneration: Arrestin-1 mutant that stimulates enolase-1 more effectively than the wild-type protein increases lactate output of photoreceptors in vivo and slows down the decline in the photoreceptor function and retinal degeneration in mice with disease-causing rhodopsin mutation, suggesting that it might be suitable for gene therapy of retinal degeneration [193].